| |
Infant sex
|
---|
|
All participants (N = 496)
|
Male infants (N = 248)
|
Female infants (N = 248)
|
---|
Maternal B vitamin
|
β coefficient, standard error, p value
|
---|
B12
| | | |
≤322.47 ng/L
|
Reference
|
Reference
|
Reference
|
322.48–446.04 ng/L
|
−12.89,70.83, 0.86
|
59.38, 104.12,0.58
|
−29.38, 101.01,0.77
|
446.05–575.51 ng/L
|
−35.89, 69.24, 0.60
|
−59.18, 105.57,0.58
|
13.55, 95.10, 0.88
|
>575.51 ng/L
|
1.85, 69.82, 0.98
|
108.19, 100.01,0.28
|
−63.02, 99.61,0.53
|
p for interaction
|
0.5276
|
PLP
| | | |
≤3.76 nM/L
|
Reference
|
Reference
|
Reference
|
3.77–7.47 nM/L
|
−72.75, 71.50, 0.31
|
3.37, 106.39, 0.97
|
−126.43, 102.07, 0.22
|
7.48–12.05 nM/L
|
−45.61, 73.22, 0.53
|
−28.02, 114.15, 0.81
|
−15.02, 99.25, 0.88
|
>12.05 nM/L
|
39.81, 75.75, 0.60
|
43.48, 119.08,0.72
|
56.05, 100.69, 0.58
|
p for interaction
|
0.7014
|
PA
| | | |
≤2.06 nM/L
|
Reference
|
Reference
|
Reference
|
2.07–3.21 nM/L
|
−13.80,70.48, 0.84
|
−50.67, 108.60, 0.64
|
49.43, 96.66, 0.61
|
3.22–5.93 nM/L
|
−35.02,70.51,0.62
|
−7.31, 107.61,0.95
|
−36.80, 95.43,0.70
|
>5.93 nM/L
|
9.95, 72.43, 0.89
|
16.03, 112.20, 0.89
|
35.43, 97.44, 0.72
|
p for interaction
|
0.9134
|
Hcy
| | | |
≤4.40 umol/L
|
Reference
|
Reference
|
Reference
|
4.41–5.10 umol/L
|
−57.72, 70.94, 0.42
|
−143.95, 108.74, 0.19
|
27.65, 95.21, 0.77
|
5.11–6.00 umol/L
|
−72.86,71.21,0.31
|
−275.57, 105.70,0.01
|
76.91, 98.03, 0.43
|
>6.00 umol/L
|
−87.21, 70.48, 0.22
|
−210.40, 102.08, 0.04
|
27.33, 98.14, 0.78
|
p for interaction
|
0.1021
|
- Adjusted for gestational age at delivery, gestational age at blood draw, maternal pre-pregnancy body mass index, maternal race/ethnicity, parity, household income and maternal smoking
-
B
12
vitamin B12, PLP pyridoxal phosphate, PA 4-pyridoxic acid, Hcy homocysteine